LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 29.92 | 84.90 | 1496 | 2237 | 0.6685 | 0.8365 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 29.92 | 84.90 | 1363 | 2237 | 0.6091 | 0.8006 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 29.92 | 84.90 | 1450 | 2237 | 0.6480 | 0.8244 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 31.62 | 84.90 | 1460 | 2449 | 0.5960 | 0.7976 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 31.62 | 84.90 | 1556 | 2449 | 0.6352 | 0.8214 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 31.62 | 84.90 | 1449 | 2449 | 0.5915 | 0.7948 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 31.62 | 84.90 | 1519 | 2449 | 0.6201 | 0.8124 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 33.32 | 84.90 | 1535 | 2722 | 0.5638 | 0.7836 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 33.32 | 84.90 | 1623 | 2722 | 0.5962 | 0.8036 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 33.32 | 84.90 | 1483 | 2722 | 0.5447 | 0.7713 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 33.32 | 84.90 | 1558 | 2722 | 0.5723 | 0.7889 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 35.03 | 84.90 | 1618 | 2991 | 0.5409 | 0.7746 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 35.03 | 84.90 | 1697 | 2991 | 0.5673 | 0.7911 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 35.03 | 84.90 | 1554 | 2991 | 0.5195 | 0.7607 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 35.03 | 84.90 | 1621 | 2991 | 0.5419 | 0.7752 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 36.73 | 84.90 | 1694 | 3254 | 0.5205 | 0.7666 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 36.73 | 84.90 | 1754 | 3254 | 0.5390 | 0.7783 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 36.73 | 84.90 | 1618 | 3254 | 0.4972 | 0.7512 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 36.73 | 84.90 | 1688 | 3254 | 0.5187 | 0.7654 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 38.43 | 84.90 | 1783 | 3459 | 0.5154 | 0.7669 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 38.43 | 84.90 | 1837 | 3459 | 0.5310 | 0.7768 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 38.43 | 84.90 | 1674 | 3459 | 0.4839 | 0.7462 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 38.43 | 84.90 | 1731 | 3459 | 0.5003 | 0.7571 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 40.14 | 84.90 | 1839 | 3682 | 0.4995 | 0.7603 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 40.14 | 84.90 | 1909 | 3682 | 0.5185 | 0.7725 | MN20160318_Q02 | L07 |